Similar articles

• Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).

  Sallee FR, Eaton K. Sallee FR, et al. Expert Opin Pharmacother. 2010 Oct;11(15):2549-56. doi: 10.1517/14656566.2010.517523. Expert Opin Pharmacother. 2010. PMID: 20831361 Review.
• Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.

  Childress AC. Childress AC. Adv Ther. 2012 May;29(5):385-400. doi: 10.1007/s12325-012-0020-1. Epub 2012 May 18. Adv Ther. 2012. PMID: 22610723 Review.
• A case of excessive weight gain with guanfacine extended release: 9.53 kg in 4 weeks.

  Khan MA, Jain G, Soltys SM, Takahashi A. Khan MA, et al. J Child Adolesc Psychopharmacol. 2012 Jun;22(3):256-7. doi: 10.1089/cap.2011.0125. Epub 2012 Apr 26. J Child Adolesc Psychopharmacol. 2012. PMID: 22537187 No abstract available.
• Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.

  Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, Lyne A, Bloomfield R, Sikirica V, Robertson B. Hervas A, et al. Eur Neuropsychopharmacol. 2014 Dec;24(12):1861-72. doi: 10.1016/j.euroneuro.2014.09.014. Epub 2014 Oct 23. Eur Neuropsychopharmacol. 2014. PMID: 25453486 Clinical Trial.
• ▼Guanfacine for ADHD in children and adolescents.

  [No authors listed] [No authors listed] Drug Ther Bull. 2016 May;54(5):56-60. doi: 10.1136/dtb.2016.5.0402. Drug Ther Bull. 2016. PMID: 27173784 Review.